<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633382</url>
  </required_header>
  <id_info>
    <org_study_id>Biliary interventional</org_study_id>
    <nct_id>NCT04633382</nct_id>
  </id_info>
  <brief_title>ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY</brief_title>
  <official_title>JUSTIFICATION OF THE PRINCIPLES OF ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vitebsk State Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vitebsk State Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to improve the immediate results after reconstructive and restorative&#xD;
      operations on the biliary tract by substantiating the management of the perioperative period&#xD;
      on the principles of &quot;enhanced recovery after surgery&quot;.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized study on the effect of fast-track surgery on the immediate&#xD;
      postoperative results after various reconstructive and restorative operations on the bile&#xD;
      ducts. In the Department of Surgical Hepatology and Transplantation, a prospective randomized&#xD;
      study will include patients (about 50) with planned reconstructive and restorative operations&#xD;
      on the bile ducts for malignant and benign diseases of the bile ducts.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of bed-days</measure>
    <time_frame>1 week</time_frame>
    <description>Improvement of basic health indicators, absence of complications, reduction of bed days</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Biliary Stricture</condition>
  <condition>Cholangiocarcinoma</condition>
  <condition>Cholangitis; Choledocholithiasis</condition>
  <arm_group>
    <arm_group_label>Conducting research of enhanced recovery after surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Informing the patient about the course of the operation and the postoperative period. Psychological preparation.&#xD;
Refusal from complete starvation. Carbohydrate drink 2 hours before surgery.&#xD;
Refusal of cleansing enemas.&#xD;
Refusal of premedication. NSAIDs 30 minutes before surgery&#xD;
Prevention of thromboembolic complications&#xD;
Multimodal analgesia: epidural catheter, paracetamol.&#xD;
Minimally invasive access.&#xD;
Prevention of hypothermia&#xD;
Targeted infusion therapy.&#xD;
Failure or limited time use of drainages: gastric, intra-abdominal, bile duct drainage.&#xD;
Early activation of the patient.&#xD;
Early enteral nutrition.&#xD;
Prevention of nausea and vomiting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conducting research of traditional recovery after surgery</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Informing the patient about the course of the operation and the postoperative period. Psychological preparation.&#xD;
Fasting for 2 days&#xD;
Use of cleansing enemas. Bowel preparation&#xD;
Premedication&#xD;
Prevention of thromboembolic complications&#xD;
Without multimodal analgesia&#xD;
Traditional access.&#xD;
Prevention of hypothermia&#xD;
Targeted infusion therapy.&#xD;
Use of drains: gastric, intra-abdominal, bile duct drainage.&#xD;
Activation of patients within 2 days.&#xD;
Enteral nutrition after 2 days after surgery.&#xD;
Without the use of metoclopramide</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Enhanced recovery after biliary tract surgery</intervention_name>
    <description>Patients with malignant and benign diseases of the bile ducts, who have formed various types of anastomosis in two options for managing the postoperative period: traditional and based on the principles of enhanced recovery after surgery</description>
    <arm_group_label>Conducting research of enhanced recovery after surgery</arm_group_label>
    <arm_group_label>Conducting research of traditional recovery after surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with malignant diseases of the biliary tract (cholangiocarcinoma):&#xD;
&#xD;
             1.1. tumor resectability 1.2. absence:&#xD;
&#xD;
               -  distant metastases&#xD;
&#xD;
               -  carcinomatosis&#xD;
&#xD;
               -  perforation of the tumor and peritonitis&#xD;
&#xD;
               -  sprouting into adjacent organs and tissues (locally advanced cancer)&#xD;
&#xD;
               -  total adhesion process in the abdominal cavity (after previous operations). 1.3.&#xD;
                  Planned reconstructive surgery on the biliary tract.&#xD;
&#xD;
          2. Patients with benign biliary tract pathology. 2.1. Planned reconstructive or&#xD;
             restorative surgery on the biliary tract for the following diseases:&#xD;
&#xD;
               -  choledocholithiasis&#xD;
&#xD;
               -  Mirizzi syndrome&#xD;
&#xD;
               -  cysts of the common bile duct&#xD;
&#xD;
               -  strictures of the common bile duct&#xD;
&#xD;
               -  injuries to the bile ducts&#xD;
&#xD;
               -  adenoma and stricture of the OBD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Scale ASA&gt; III (severe concomitant cardiovascular pathology).&#xD;
&#xD;
          2. Palliative reconstructive surgery.&#xD;
&#xD;
          3. Previously performed operations on the bile ducts (up to 1 month).&#xD;
&#xD;
          4. Cachexia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yury N Arlouski, MD</last_name>
    <phone>+375296374668</phone>
    <email>orl_doc@hotmail.com</email>
  </overall_contact>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vitebsk State Medical University</investigator_affiliation>
    <investigator_full_name>Yury Arlouski</investigator_full_name>
    <investigator_title>Associate professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Fast track, Enhanced recovery after surgery, biliary surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Choledocholithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

